The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women

Caitlin J. McCabe, Sue J. Goldie, David N. Fisman · 2010

Read The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women by Caitlin J. McCabe, Sue J. Goldie, David N. Fisman (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010154.txt.

Description

Caitlin McCabe, Sue Goldie, and David Fisman weighed a treatment plan for pregnant women with HIV in 2010. Suppressing the virus in late pregnancy prevents transmission to the baby. Directly observed therapy, where staff watch each dose, improves that suppression. Their PLOS ONE study projected both effectiveness and cost for the third trimester.

Cost-effectiveness analysis asks whether the health gained is worth the money spent. Watched therapy costs more to deliver than handing over pills. If it prevents enough infant infections, it may be the better buy. Their model was built to make that judgment for health systems.

Catalog record

CREATORCaitlin J. McCabe, Sue J. Goldie, David N. Fisman
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE56 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010154

Browse the full library · About the Tower of Babel